Tiverton Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$635K Sell
17,327
-284
-2% -$11.3K 0.02% 348
2019
Q2
$819K Sell
17,611
-4,909
-22% -$231K 0.03% 299
2019
Q1
$904K Buy
22,520
+940
+4% +$42.2K 0.04% 254
2018
Q4
$992K Sell
21,580
-4,206
-16% -$203K 0.06% 179
2018
Q3
$1.14M Buy
25,786
+22,199
+619% +$1.02M 0.06% 190
2018
Q2
$140K Sell
3,587
-30,593
-90% -$1.55M 0.01% 353
2018
Q1
$2.47M Buy
34,180
+25,786
+307% +$1.89M 0.17% 107
2017
Q4
$553K Sell
8,394
-5,823
-41% -$314K 0.03% 233
2017
Q3
$713K Sell
14,217
-1,877
-12% -$90.5K 0.04% 160
2017
Q2
$745K Sell
16,094
-5,231
-25% -$192K 0.04% 166
2017
Q1
$753K Hold
21,325
0.04% 170
2016
Q4
$267K Hold
21,325
0.02% 187
2016
Q3
$295K Sell
21,325
-34,738
-62% -$394K 0.02% 155
2016
Q2
$2.94M Sell
56,063
-53,297
-49% -$883K 0.12% 124
2016
Q1
$1.85M Sell
109,360
-11,195
-9% -$180K 0.06% 141
2015
Q4
$2.68M Sell
120,555
-15,000
-11% -$378K 0.09% 133
2015
Q3
$3.2M Hold
135,555
0.07% 136
2015
Q2
$11.1M Buy
135,555
+25,455
+23% +$2.49M 0.22% 105
2015
Q1
$10.2M Buy
+110,100
New +$7.11M 0.21% 103

Other funds holding ESPR